N/A Completed N=802 Randomized Screening

Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia

Cervical carcinoma · Human Papillomavirus Infection

Source: ClinicalTrials.gov NCT04411849 ↗

Enrolled (actual)

802

Serious AEs

0.0%

Results posted

Dec 2024

Primary outcomePrimary: Effectiveness of Human Papillomavirus (HPV) Intervention — 69; 17 Participants

Summary

This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occur among unscreened and underscreened women. A multilevel HPV self-testing intervention may help to improve cervical cancer screening rates.

Outcome Measures

Outcome	Result	p-value
PRIMARY Effectiveness of Human Papillomavirus (HPV) Intervention	69; 17	—

Eligibility Criteria

Inclusion Criteria

Not within recommended cervical cancer screening guidelines for women in this age range (i.e., no Papanicolaou [Pap] test in last 3 years or no Pap test plus clinic-based HPV test in last 5 years)
Resident of an Appalachian county
Not currently pregnant
Intact cervix
No history of invasive cervical cancer
Seen in a participating clinic/health system in last 2 years (i.e., active patient)
Have a working telephone

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04411849). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.